Benefits of lixilan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide, versus insulin glargine and lixisenatide monocomponents in type 2 diabetes inadequately controlled on oral agents: the LixiLan-O randomized trial
Activates fibroblasts, stimulates collagen and elastin synthesis, promotes angiogenesis, and modulates inflammatory responses for optimal skin regeneration References Important Note This content is intended for educational purposes only and is not medical advice, diagnosis, or treatment
However, their use in clinical practice is often limited, due to lacking analytical or clinical validation, or technical challenges
Monitoring and Bloodwork Running a dual-peptide protocol without monitoring your biomarkers is like driving with your eyes closed
While muscle loss is standard with any diet or weight-loss regimen, loss of muscle on GLP-1s can be more dramatic, Ahmed says, causing what's been dubbed "Ozempic face," a bonier, looser-skinned look, where the muscle loss is particularly noticeable